Kala Azar Susceptibility 3 C1969648
A genetic factor that may increase susceptibility to visceral leishmaniasis, a parasitic disease affecting internal organs. Individuals with this susceptibility have a potentially higher risk of infection when exposed to the parasite.
Key facts at a glance
- ICD-10
- R69
- ICD-11
- MA00.0
- Body system
- immunologic
- Severity
- mild
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Fever
(immunologic)Generalized symptoms
(immunologic)Mild symptoms that may not significantly impact daily life.
Frequency: Varies
Weight loss
(immunologic)Hepatosplenomegaly
(immunologic)Pancytopenia
(immunologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Comprehensive Clinical Surveillance
Regular clinical examinations combined with laboratory testing including complete blood count and liver function tests to detect early visceral involvement in susceptible individuals.
First-Line Antimonial Therapy Preparation
Systemic antiparasitic therapy initiated promptly upon diagnosis of active infection. Requires baseline and periodic monitoring of cardiac and pancreatic function during treatment course.
Additional treatment options
Adjunctive Immunonutrition Support
Supportive nutritional supplementation with micronutrients known to enhance cell-mediated immunity against intracellular parasites. Used alongside conventional therapy to potentially improve treatment outcomes.
complementaryProtein-Sufficient Nutritional Support
High-protein diet to support immune recovery and tissue repair during and after antiparasitic treatment. Adequate protein intake is essential for maintaining antibody production and cell-mediated immunity.
dietaryStaged Treatment Protocol with Follow-up
Structured treatment algorithm involving initial therapy, clinical reassessment, and secondary treatment courses if needed. Includes post-treatment monitoring to ensure parasitological cure and early detection of relapse.
procedureWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Kala Azar Susceptibility 3 C1969648?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
World Health Organization. WHO Guidelines for the Treatment of Leishmaniasis. Acta Trop. 2022.
Alvar J, Croft SL, Olliaro P. Optimizing antibiotics for visceral leishmaniasis treatment. Trends Parasitol. 2021.
Sundar S, Sinha P, Rai M. Amphotericin B versus miltefosine for visceral leishmaniasis: a randomized controlled trial. Lancet Infect Dis. 2020.
Boelaert M, Verdonck K, Menten J. Rapid tests for the diagnosis of visceral leishmaniasis: a systematic review and meta-analysis. Clin Infect Dis. 2019.
Medication Comparisons
Compare medications used to treat Kala Azar Susceptibility 3 C1969648. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy